Member Info for leas

Lloyd, I originally bought IMM at 52 and doubled up at 19 buying a further 2 tranches on the way back up. I was also questioning my investment decisions. It was soon forgotten when I sold the lot at an avg of 177 prior to their P3 trial. Not researched here but I guess you have done your due diligence.

That's why the institution's are controlling the sp movements. Sell up would be my advice and then let the institution's do what they are good at. What did the pi's expect to hear yesterday? Details of an offer? Some guys need a reality check. We have a low MC of less than 60m with the potential of delivering with the help and funding of our partners to deliver a blockbuster drug. Sooner the gamblers move on and the institution's fill their bellies the quicker the sp will move up.

BBC news coverage about the 'Spanish Flu'. Puts in perspective the potential of the new drugs coming to market. Not forgetting humans becoming more resistant to antibiotics.

https://marketexclusive.com/hvivo-plc-lonhvo-had-its-buy-rating-reiterated-by-numis-securities/2018/09/

I would expect more buy rec. and press coverage as news is digested over the next week or so. Shares moving into the hands of investors.

Expect some positive media coverage in the next few days. I think we all have our own opinions on how and why the sp is 'behaving the way it does. Sorry for those pi's that may have sold at a loss on the hope that AZ or GSK will buy the rights to FLU-5 for 1bn. today. I will hang around for a while and see how those 75% and more perform in the hands of institution's. My investment is staying exactly where it is.

Not sure I agree with the 'Jam tomorrow' comment. Do you guys not research before buying or jump on a sudden sp rise not wanting to miss the boat. The nature of the company is to develop drugs with partnerships taking them through to market in order to generate revenue. The sp has increased 400% from the year's low, pi's are reacting to day by day price movements, lots of news due so just a bit of patience required.

Jimzi, likewise. I can still see a few fun and games but the potential in a relatively short timeframe could be massive. Tbh, yesterday I thought there would be a slight drop prior to the presentation as some investors would seize on the RNS and try to put a negative spin on it but the content is all positive.

moneygrabber, don't want to get into a debate over Brexit but the opposite does apply. Plenty of German beers on our supermarket shelves that imo are not equal to our craft beers.
I live in northern France and perhaps my view is not as polarised as some of my family members but I don't think things are going to be as bad as many Brits make out.

Excellent updates. Well done to those that have held post P11b. Lots of news that can come from different directions from their other compounds. I still think maximum share value will be unlocked in the coming months as the institutions wrestle the last 25% of shares from pi's.

The weak pound presents a good buying opportunity for the EU. British supermarkets now have he small kegs on their shelves too. Craft beers becoming more popular. Hopefully the trend will increase as Christmas approaches. Wychwood are even doing them for Halloween.

Thanks powder, not on Twitter so link is appreciated. Our partners seem very bullish on the leadup to the interims and presentations. They would look foolish if there is no news on the progress of FLU-v and the route to market.

There is no need for any RNS to be issued. The company have already informed the market of their intentions. If you have thrown your hat into the ring then just let them get on with it.

Following comment from Bernymadoff on the ADVFN bb.

'I find it intriguing as to why the company has scheduled a presentation for analysts on the 20th when the interims are released. It hasn't done this before with any results which leads me to suspect it has something important to say. Why hold a presentation unless you've got something interesting to present?

Tomorrow we should have some clarity on what the current position of the company is and maybe the NIH

marine, have to agree. LSE forum is for the 'rainbow chasers' looking to trade on momentum which is usually driven by rumour rather than facts. I would guess a bit rich for some who hope to get rich on the back of hope. I hold MARS so read bb's in this sector to gauge sentiment and see if there is any news of interest.

Appears so. Rise is steady too, early days but very positive

IIand, that is what I don't get. Im sure we all could post a list of profitable companies that would be easier to short. I did not invest on the hope that the company will be taken over though. I invested for the yield and capitol growth. It will all come out in the wash eventually. I still think 116 is their baseline, anything below that and they risk heavy buying pressure.

algos trying to pull us back again. Despite some investors thinking that short selling is good for the financial sector I still think it is a corrupt practice. This is a perfectly sound business, good growth strategy and a competent Board. I know margins are being squeezed but imo that is offset by the in house Vets.

Perhaps he wants to maximise the value of his shares going forward. :) On his appointment, he made the following statement. ' I look forward to working with the Board and wider executive management team to maximise the future opportunities open to the Group going forward."
I wonder what he knows? Is it MARS growth strategy? Maybe by the 1st of October he will add to those comments. No denying that the sp has risen by over 10% since the announcement.

Djm, the sp has risen from just over 4p. You post that comment when the sp is 9p. Priceless. Couldn't make it up.

Jimmy, following link may help you grasp why companies grant share options. Perfectly above board and nothing dodgy. Even if they announced news on the same day.
https://www.nibusinessinfo.co.uk/content/defining-share-option-and-share-award-schemes